Proprietary DNA sequencing platform
Omniome, a biotechnology company based in San Diego, is developing a proprietary DNA sequencing platform to deliver unsurpassed sequencing accuracy.
-
Domain
-
Investment typeDirect equity
-
StatusExit
-
Initial investmentSeries A
-
Partnered in2016
-
HeadquartersUSA
-
Program strategyTuberculosis
More about our work
Our focus
Our six domains of focus comprise 40+ program strategies across the Foundation’s nearly $9B annual charitable support.
Investment approach
Fostering partnerships with the private sector to leverage groundbreaking global innovations for societal good.
Our team
We bring depth of experience to every investment, with a proven track record across sectors and scale.